BCM
ALAB icon

BluePath Capital Management’s Astera Labs ALAB Stock Holding History

BluePath Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
+501
New +$133K 0.13% 120
2025
Q4 		– Sell
-1,125
Closed -$220K – 108
2025
Q3 		$220K Buy
+1,125
New +$185K 0.16% 85

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BluePath Capital Management's ALAB Position: Q2 2026 in Review

BluePath Capital Management opened a new position in Astera Labs (ALAB) in Q2 2026: 501 shares worth $242K. The stake represents 0.13% of the portfolio and ranks #120 among its holdings. This is a return to the name: BluePath Capital Management previously reported a position in ALAB as recently as Q3 2025.

BluePath Capital Management first reported a position in ALAB in Q3 2025 and has held it in 2 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • BluePath Capital Management held 501 shares of Astera Labs worth $242K as of Q2 2026.
  • Astera Labs was a new BluePath Capital Management position in Q2 2026.
  • Astera Labs made up 0.13% of BluePath Capital Management's portfolio in Q2 2026, its #120 holding.
  • BluePath Capital Management first reported a position in Astera Labs in Q3 2025 and has held it in 2 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.